Abstract: A radio communication apparatus for generating a pulse signal corresponding to a data signal, amplifying the generated pulse signal, and transmitting the amplified pulse signal as a radio signal, the apparatus including: a reference pulse signal generation unit which generates a reference pulse signal of opposite phase to the pulse signal and amplifies the reference pulse signal; and a combining unit which combines the amplified pulse signal and the amplified reference pulse signal, wherein a combined pulse signal output from the combining unit is transmitted as the radio signal.

Abstract: a communication apparatus includes: a pulse generation unit configured to alternately generate a positive pulse and a negative pulse indicating presence or absence of a pulse in accordance with a value of a data signal; a band-pass filter configured to filter the pulse generated by the pulse generator; and a transmission amplifier configured to amplify a signal filtered by the band-pass filter, and to output the signal as a transmission signal.

Abstract: With an aim to provide means for developing a compound devoid of teratogenicity but retaining beneficial actions, a screening method for a non-teratogenic substance comprising bringing a test substance into contact with cereblon or a fragment of cereblon, evaluating the bindability of the test substance with cereblon or the fragment of cereblon, and selecting a test substance that does not bind to cereblon or the fragment of cereblon or a test substance exhibiting lower bindability with cereblon or the fragment of cereblon than does thalidomide is provided.

Abstract: With an aim to provide a novel factor inducing proliferation of neural stem cells and differentiation of these cells into nerve cells, a pharmaceutical composition comprising 1) CRBN, 2) a nucleic acid encoding CRBN, or 3) a stem cell or a neural progenitor cell in which CRBN is expressed, a method including administering the pharmaceutical composition to a non-human animal and inducing proliferation of neural stem cells or neural progenitor cells of the non-human animal and differentiation of these cells into nerve cells, and a method for screening for a therapeutic drug for a disease of cerebral cortex or a surgical injury of cerebral cortex, using CRBN, are provided.

Abstract: A multilayer printed-circuit board includes at least one inner-layer signal line, first and second ground layers between which the inner-layer signal line is sandwiched via a frame member made of an insulating material in a thickness direction of the multilayer printed-circuit board, and metallic wall members which are provided on inner walls of slits formed in the frame member and extending along the inner-layer signal line. The first and second ground layers and the metallic wall members shielding the inner-layer signal line.